Xiao Noodles Posts Maiden Annual Results: Revenue and Net Profit Jump in 2025 as ESG Efforts Drive Long-Term Value

HONG KONG, Apr 29, 2026 - (ACN Newswire via SeaPRwire.com) - In 2025, China's catering industry surpassed RMB5.7 trillion in total market size, maintaining steady and healthy growth momentum. The sector has shifted its focus from scale expansion to efficiency improvement and structural optimization, entering a new stage of high-quality development. The industry’s chain store ratio climbed for six consecutive years to 25%, with food delivery penetration exceeding 30%. AI and supply chain technologies are further reshaping operational models across the sector. Amid this structural adjustment, Xiao Noodles, a leading and rapidly growing Chinese noodle restaurants operator in China, has secured a solid foothold amid industry reshuffling by focusing on operational efficiency, product quality and long-term value creation.Rising Profitability with Robust Growth in Scale and Performance As the “First-listed Chinese Noodle Restaurant”, Xiao Noodles (2408.HK) unveiled its inaugural financial results since its listing. During the Reporting Period, the Company posted total revenue of RMB1,622.4 million, a year-on-year increase of 40.5%. Its net profit reached RMB106.1 million, representing a year-on-year growth of 74.8%. Adjusted net profit stood at RMB135.4 million, up 111.9% year on year, reflecting a sustained improvement in profitability. By the end of 2025, the brand’s total restaurant network had expanded to 503 outlets.Driven by the expansion of self-operated restaurants, revenue from self-operated restaurants rose by 44.9% year on year from RMB1.00 billion in 2024 to RMB1.45 billion in 2025. Its revenue contribution increased from 86.7% in 2024 to 89.4% in 2025, demonstrating strong resilience of the self-operated model. Meanwhile, the proportion of food delivery revenue in total revenue jumped from 15.6% in 2024 to 23.3% in 2025, emerging as a new key driver of overall revenue growth.In terms of operational efficiency, the average daily orders per restaurant for its self-operated restaurants and franchised restaurants increased from 386 and 390 in 2024 to 406 and 412 in 2025, respectively. As of the end of 2025, Xiao Noodles had 395 self-operated restaurants and 92 franchised restaurants in 24 cities in the Chinese Mainland, 15 restaurants in Hong Kong SAR and one restaurant in Singapore, steadily advancing its national and international expansion.While achieving steady operational growth, the Company has maintained a strong commitment to shareholder returns. The Board proposed a final dividend of RMB0.03 per H share for fiscal 2025, representing a payout ratio of over 50%. This proposal not only delivers tangible returns to shareholders for their long-term support, but also underscores the Company’s financial health, characterized by genuine profitability and robust cash flows. It further enhances investor confidence and trust in the Company’s corporate governance and brand value.Deepening ESG Practices: Public Welfare and Talent Co-create Long-term ValueAs ESG becomes a core measure of long-term corporate value for measuring a company’s long-term value, Xiao Noodles has embedded social responsibility into its business model, emergency response, and talent investment. In 2025, its public welfare donations reached RMB1.4 million.Since 2023, the Company has launched the “Baobao Meal Charity Program”, donating RMB0.1 for every baby meal sold for public welfare purposes. As of the end of 2025, approximately 2.18 million baby meals had been sold cumulatively, generating public welfare funds of approximately RMB218,000. This has created a virtuous cycle: rising sales - a larger pool of charitable funds - stronger brand reputation. In September 2025, the Company, together with the Shanghai United Foundation, donated RMB100,000 to launch the “An Egg Donation Activity,” providing rural children with a daily egg and nutrition education courses. Through tangible actions, the initiative focuses on supporting the health and education of underprivileged children. In terms of talent and innovation investment, the Company partnered with South China University of Technology to establish the “Campus Culture Construction Fund” and the “Innovation and Entrepreneurship Public Welfare Fund.” In 2024, the Company donated RMB600,000, with a planned cumulative donation of RMB3 million over five years. An additional RMB300,000 was contributed in 2025, demonstrating its ongoing commitment to supporting education and cultivating innovative talent.In response to emergencies, the Company has demonstrated a well-established emergency response capability. Following the fire incident at Wang Fuk Court in Tai Po, Hong Kong, in November 2025, the Company activated its emergency charitable response mechanism on the same day and donated HKD1 million to support the resettlement of affected residents, reflecting a robust ESG governance structure and effective authorization mechanisms.In addition, the Company places strong emphasis on internal talent development, adhering to the philosophy that “Talent Drives Development,” and provides employees with continuous learning and career advancement opportunities. During the reporting period, the employee training coverage rate reached 100%, with a total of 40,756 training hours and an average of 19.8 hours per employee, ranking at a relatively high level within the industry. The Company has established an online training system based on digital infrastructure, offering standardized training programs and comprehensive on-boarding training for new employees to ensure consistency in professional standards and service experience. While reducing talent development costs during store expansion, this system also shortens the ramp-up period for new stores, thereby securing a stable talent supply chain to support rapid expansion.From product-driven micro-philanthropy to targeted engagement with specific social issues, and further to long-term investment in education, rapid crisis response, and internal talent development, Xiao Noodles has established a clear path that balances “the integration of business and social welfare, as well as short-term and long-term priorities.” In doing so, the Company has also built strategic assets that enhance brand premium, reduce employee turnover, and strengthen investor confidence.Forward-Looking Industry Positioning with Promising Growth PotentialFrom an industry perspective, the Chinese fast-casual dining sector is accelerating its transformation toward standardization, digitalization, and branding. Firstly, consumer demand for healthy, convenient, and cost-effective dining options continues to rise, benefiting leading players with strong supply chain capabilities and economies of scale as market concentration increases. Secondly, AI and automation technologies are reshaping cost structures, with applications such as intelligent workforce scheduling, precise inventory management, and autonomous delivery gradually being implemented, further unlocking technological dividends. In addition, ESG performance has become a key metric for assessing the long-term value of restaurant enterprises, as non-financial factors such as green stores, low-carbon operations, and community responsibility increasingly influence both capital allocation and consumer choice. Leveraging its strengths in product innovation, operational efficiency, and early-mover advantage in ESG practices, Xiao Noodles is well positioned to further expand its market share within its niche segment.Overall, in 2025, Xiao Noodles delivered an exceptional dining experience through flavorful dishes, high-quality service, and a distinctive dining atmosphere. The Company achieved notable results in profitability, financial optimization, shareholder returns, and green practices, successfully transitioning from scale-driven expansion to quality-driven growth. Looking ahead, as industry consolidation accelerates and digitalization and ESG initiatives gain traction, the Company's competitiveness is expected to strengthen further, driving its results of operations to a new height and injecting strong momentum into the high-quality development and green transformation of the industry. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

无敌少侠游戏引入震撼时间线转折

Skybound Games(SeaPRwire) -   在这个漫威电影宇宙曾经享有的文化主导地位似乎正逐渐减弱,而DC漫画仍在试图让某个连贯的共享宇宙版本步入正轨的时代,我们对超级英雄媒体的持续热爱正由两大巨头框架之外的故事所支撑。Amazon对黑袍纠察队的改编剧集大获成功,播出了五季,尽管它及其设定在年轻成人大学校园的衍生剧Gen V即将完结,但即将到来的前传Vought Rising意味着其将超级英雄视为军事宣传和资本主义广告代言人的愿景将以某种形式继续存在。Amazon还拥有另一部当前备受关注、不属于漫威或DC的超级英雄作品:《无敌少侠》,这是对罗伯特·柯克曼长达近20年的超级英雄讽刺/恶搞/史诗作品的改编。原版漫画之所以成功,很大程度上在于柯克曼既能调侃又能融入长期存在的超级英雄趋势的能力:行走的大规模杀伤性武器之间轻若无物的战斗、过多的平行宇宙、死亡的无意义性、公司范围内的重启。Amazon的改编版至今仍能让人感到新鲜和引人入胜,部分原因在于它现在能够回应一个仍在重复这些趋势的更庞大的超级英雄媒体生态系统,同时为了新的媒介和新的观众更新了故事的某些方面。现在,马克·格雷森和他的配角阵容正寻求在另一个新媒介中,并借助一个巧妙的噱头来重现这些成功。即将推出的电子游戏Invincible VS(由Quarter Up开发,Skybound Games发行)的新故事预告片,让我们首次真正看到了驱动游戏构思的核心想法。Skybound Entertainment由柯克曼本人创立,他与游戏编剧共同构思了故事:一个旨在通过追问"如果诺兰从未改变,而是率领几位主要的维尔特鲁姆人反派返回地球会发生什么"来重写马克作为无敌少侠命运的故事。该游戏主要基于Amazon的剧集,部分演员回归(吉莉安·雅各布斯饰演原子伊芙,J·K·西蒙斯饰演全能侠),但也有几位演员更换(亚历克斯·勒饰演无敌少侠,加文·哈蒙德接替沃尔顿·戈金斯饰演塞西尔等)。Invincible VS设定在平行宇宙,这与更广泛的系列作品完美契合;漫画在2009年的"无敌战争"故事线中相当早就引入了这一概念,该剧在第三季改编了这部分内容。根据该剧对原著素材的紧密遵循程度,尤其是在传奇故事的结尾部分,这不会是马克最后一次遭遇他生活的另一个版本。知道还存在另一个重大的时间线变体,其中有待揭晓的转折(游戏中征服者的出现意味着故事不会局限于剧集的第一篇章),这既有趣又引人入胜,同时,设想剧集中的无敌少侠和游戏中的无敌少侠有可能相遇也令人兴奋。不知何故,Quarter Up和Skybound在创造一个更加无可救药的诺兰版本方面超越了预期。| Skybound Games这个想法也与电子游戏非常注重冲突的性质很好地协同起来。柯克曼此前曾表示,格斗游戏是无敌少侠的完美载体,因为它既能展示庞大的角色阵容,又能让玩家以另一种方式体验他们战斗的纯粹残酷性。但这也是对漫画和剧集主题的一种微妙而深思熟虑的呼应;故事之所以以意想不到的方式发展和转变,很大程度上是因为马克能够改变他的父亲,如果这种情况没有发生,将会出现更多毁灭星球的冲突。如此多的格斗游戏将其故事模式视为多人游戏组件的次要部分,虽然该类型主要确实适合于此,但它们仍然拥有有趣的世界和角色,这些元素本可以从同样有趣的叙事中受益。即使最终的重点是令人满意的超级英雄痛殴,但知道Invincible VS同时提供了一个真正引人入胜的叙事也是件好事。Invincible VS将于2026年4月30日在Xbox Series X/S、PlayStation 5和PC平台发售。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

遇见小面首份财报出炉:2025年收入净利双增 ESG实践助力长期价值

香港, 2026年4月29日 - (亚太商讯 via SeaPRwire.com) - 2025年,中国餐饮行业总量突破5.7万亿元,呈现稳中有进的良好态势,发展重心由规模扩张转向效率提升与结构优化,迈入高质量发展的新阶段。行业连锁化率连续六年攀升至25%,外卖渗透率超过三成,AI与供应链技术加速重塑运营逻辑。在这轮结构性调整中,作为中国领先且快速增长的中式面馆经营者,遇见小面凭借深耕效率、品质与长期价值,在行业洗牌中占据稳固地位。盈利能力稳步提升,规模效益双增 近期,"中式面馆第一股"遇见小面(2408.HK)披露上市后首份财报。报告期内,公司实现收入人民币1,622.4百万元,同比增长40.5% ;实现净利润人民币106.1百万元,同比增长约74.8%;录得经调整净利润人民币135.4百万元,同比增加约111.9%,盈利能力持续改善。截至2025年底,公司餐厅总数已增至503家。得益于直营餐厅数量增长,来自直营餐厅经营的收入由2024年的人民币1,001.0百万元增加4 4 . 9%至2025年的人民币1,450.2百万元,该部分收入占比由2024年的 86.7%上升至2025年的89.4%,展现出直营模式的增长韧性。同时,外卖业务收入占总收入比例由2024年的15.6%快速上升至2025年的23.3%,成为收入增长的新动力。运营效率方面,直营及特许经营餐厅的单店日均订单分别由2024年的386及390增至2025年的406及412。截至2025年底,遇见小面在中国内地24个城市拥有395家直营餐厅及92家特许经营餐厅,在香港特别行政区有15家餐厅,在新加坡有1家餐厅,全国化与国际化布局稳步推进。在业绩稳健增长的同时,公司高度重视股东回报。董事会建议派付截至2025年12月31日止年度的末期股息,每股H股人民币0.03元,2025年整体股息支付率超50%。此举不仅是对股东长期支持的实质性回报,也彰显了公司盈利真实、现金流充沛的财务健康度,进一步增强投资者对公司治理水平与品牌价值的认可度和信任度。ESG实践纵深:公益与人才共筑长期价值在ESG成为衡量企业长期价值核心标尺的当下,遇见小面已将社会责任嵌入商业模式、应急响应与人才投资之中。2025年度公益捐赠达人民币140万元。自2023年起,公司推出"宝宝餐公益计划",每售出一份宝宝餐即捐出0.1元用于公益用途,截至2025年底累计售出约218万份,汇聚公益资金约21.8万元,形成"销量增长—公益池扩大—品牌美誉度提升"的正向循环。2025年9月,公司联合上海联劝公益基金会捐资10万元发起"一个鸡蛋爱心捐赠活动",为乡村儿童提供每日鸡蛋及营养课程,以实质行动聚焦弱势儿童健康与教育支持。在人才创新投资方面,公司与华南理工大学合作设立"校园文化建设基金"及"创新创业公益基金",2024年捐赠60万元,计划五年内累计捐赠300万元,2025年再捐30万元,持续支持教育与创新人才培育。面对突发灾害,公司展现出成熟的应急响应能力。2025年11月香港大埔宏福苑火灾发生后,公司当天启动公益应急机制,捐出100万港元用于受灾住户安置,体现了完善的ESG管治架构与授权机制。此外,公司高度重视内部人才发展,秉持"人才促进发展"理念,为员工提供持续学习与职业晋升机会。报告期内,全体员工受训率达100%,累计培训时长40,756.2小时,人均19.8小时,处于行业较高水平。公司建立了基于数字化基础设施的在线培训系统,提供标准化的培训计划,并为新员工提供入职综合培训,确保专业标准与服务体验的一致性。在降低门店扩张中的人才培养成本的同时,也缩短了新店爬坡期,为高速开店提供人才供应链保障。从产品驱动的微公益到精准社会议题介入,再到长期教育投资、危机快速响应与内部人才培训,遇见小面不仅形成"商业与公益共生、短期与长期并重"的清晰路径,更构建了提升品牌溢价、降低员工流失率、增强投资者信心的战略性资产。行业趋势前瞻布局,成长空间可期从行业发展趋势来看,中式快餐赛道正加速向标准化、数字化、品牌化方向升级。首先,消费者对健康、便捷、高性价比餐饮的需求持续提升,具备强供应链能力和规模效应的头部企业将受益于市场集中度提高。其次,AI与自动化技术深度重构成本结构,智能排班、精准库存、无人配送等应用逐步落地,技术红利进一步释放。此外,ESG表现已成为衡量餐饮企业长期价值的关键指标,绿色门店、低碳运营、社区责任等非财务因素日益影响资本与消费者的选择。遇见小面在细分赛道中凭借产品创新、运营效率和ESG先发优势,有望持续扩大市场份额。综合来看,2025年遇见小面通过美味菜肴、优质服务及独特的用餐氛围向顾客提供极致用餐体验,在盈利表现、财务优化、股东回报、绿色实践等方面取得诸多亮眼成绩,成功实现从规模扩张向质量驱动的转型。未来,随着行业集中度提升、数字化与ESG战略的深入推进,公司的核心竞争力将持续增强,经营业绩有望再上新台阶,为行业高质量发展与绿色转型注入强劲动能。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HBO Max 一直在悄然推出这部最出人意料的反乌托邦传奇剧集

(SeaPRwire) -   好莱坞热衷于拍摄关于自身的项目早已不是秘密。从《雨中曲》到《艺术家》再到《杰伊·凯利》,任何关于我们称之为"演艺"这个行业的作品,都必定会受到业内工作者的追捧。最近,这一趋势已延伸至电视剧领域,《制片厂》成为这一"圈内秘辛"题材的最新玩家。但早在19年前,就有一部剧集走在了前沿:《归来记》。迈克尔·帕特里克·金在2007年推出的这部剧集由丽莎·库卓饰演瓦莱丽·切莉什,一位过气的喜剧明星,她在拍摄一部新剧的同时,也参与了一部关于她重返行业的纪实真人秀。七年后,在电视剧的黄金时代2014年,《归来记》回归推出了第二季,讲述了瓦莱丽主演一部HBO精品剧集并赢得艾美奖的故事。如今,《归来记》带着第三季也是最终季回归,这次它聚焦于另一个电视热点话题——人工智能。但与之前几季不同,它展现了一个(幸好)尚未发生的最坏情况:人工智能完全取代编剧,负责一部电视网的剧集创作,将整个系列变成了一则警示性的反乌托邦故事。警告!以下内容包含《归来记》第三季剧透。《归来记》第三季展现了人工智能技术危险的近未来图景。| HBO《归来记》第三季开场,瓦莱丽·切莉什出现在WGA/SAG-AFTRA罢工的纠察线上,她特意与SAG主席弗兰·德雷舍尔合影以便发布在社交媒体上。我们知道她的立场,但她自己真的清楚吗?当瓦莱丽受邀主演一部名为《怎么说?》的新情景喜剧时,尽管电视网负责人告诉她这部剧是由AI在人类编剧辅助下撰写的,她还是接下了这个角色。"现在到处人人都在担心AI,对吧?而我呢,倒是很兴奋能放手看看AI到底是怎么回事,"瓦莱丽在多次无视她的GPS导航之前这样说道。在瓦莱丽长期合作的纪录片制作人朋友简(劳拉·西尔弗曼饰)的跟拍下,瓦莱丽很快得知了令人不安的真相。虽然人类编剧参与了创作过程,但他们更像是程序的"保姆",而这个程序最终失控,甚至在那部温馨的B级情景喜剧中"幻想"出了《神秘海域》系列里的内森·德雷克。这让瓦莱丽彻底失去了方向,她试图寻找人类编剧来帮助打造这部系列剧,使其成为她职业生涯所需的复出之作。在《归来记》第三季中,AI成为一部新情景喜剧的主要编剧。| HBO在最新一集中,简透露她从未签署过关于在《怎么说?》中使用AI的保密协议,最终整个行业都发现了《怎么说?》肮脏的小秘密。"人们有权知道AI正在抢走他们的工作。不仅仅是在办公室和工厂。就在这里,在这部愚蠢的情景喜剧里,"简说道。"我必须向他们表明,这不是未来某个地方才会发生的事。它已经在这里了。"这可能还不是行业的现状——至少据我们所知——但这可能是未来发展的一个征兆。当《归来记》第一季在2007年首播时,真人秀电视仍然是一种冒险的尝试,主要局限于像《幸存者》和《极速前进》这样的竞赛类节目。但愿第三季不会像以前那样具有预见性,但即使没有,它也描绘了一个警示故事,讲述了当创造力被剥夺了所有使其具有人性特质的东西时会发生什么。当然,AI可以在几分钟内,利用少量环境资源就炮制出50个笑点,但它无法创作出具有人情味的东西,即使在虚构作品中也不行。《归来记》现已在HBO Max上线播出。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

21年后,原版蒙面英雄回归大银幕——带来意外转折

Silver Screen Collection/Archive Photos/Getty Images(SeaPRwire) -   唐·迭戈·德·拉·维加,也就是那位蒙面义侠佐罗,已经是一个许久未见的角色了。(具体来说,距离那部被其维基百科页面风趣地描述为“剑侠”电影的《佐罗传奇》在影院上映,已经过去了21年。)这实在可惜——在这个贫富极度不均的时代,一个为贫苦和受压迫者而战、对抗腐败贪婪势力的角色,本应受到美国公众的热烈欢迎。但是等等!那个抓着丝绸窗帘荡进敞开的窗户的人是谁?正是《Django/Zorro》——一部由Sony Pictures最近委托布莱恩·海尔格伦创作的剧本,他曾凭借《洛城机密》和《神秘河》的剧本获得奥斯卡提名。(更近一些,他编写了吴宇森翻拍自己旧作《喋血双雄》的剧本,该片于2024年在Peacock平台悄然上线,几乎未引起任何轰动。)对海尔格伦来说,这是又一次改编工作:除了分别源自昆汀·塔伦蒂诺2012年的电影《被解救的姜戈》——这里指的是曾是奴隶的赏金猎人姜戈,不是那个拖着棺材到处走的意大利牛仔——和1919年的小说《卡普斯特拉诺的诅咒》之外,姜戈和佐罗首次相遇是在一本同名漫画书《Django/Zorro》中。这部七期的Vertigo大事件系列由塔伦蒂诺和漫画创作者马特·瓦格纳共同编写,瓦格纳以创作《Grendl》和《Mage》系列而闻名。(西班牙艺术家埃斯特夫·波尔斯负责作画。)《Django/Zorro》是第一部——并且在很长一段时间里是唯一一部——任何昆汀·塔伦蒂诺电影的官方续集。(从技术上讲,它现在仍然是,因为那个可恶的《堡垒之夜》联动事件在技术上发生在《杀死比尔1》和《杀死比尔2》之间。)作为一个团队,姜戈和佐罗的组合是合理的:他们都是字面意义上的社会正义战士,致力于保护受压迫者,而且两人都颇具风格。(可以想象这两人一起去买帽子的情景。)在漫画中,姜戈同意在一次解救一群被奴役的原住民的任务中担任佐罗的保镖,并与他在加利福尼亚的这位搭档建立了融洽的关系,类似于姜戈在原版《被解救的姜戈》中与金·舒尔茨医生(克里斯托弗·瓦尔兹 饰)的关系。据《Variety》报道,电影版的《Django/Zorro》将包含一个具有相同角色的新故事,但核心概念——以侠盗般的风格惩罚恶人——大概会保持不变。这个剧本本身在好莱坞经历了一段漫长而奇特的旅程:这部电影已经存在多个草稿版本,其中包括由喜剧演员杰罗德·卡迈克尔编写的一版,他早在2022年就告诉GQ:“实际上,从那之后来了一个非常、非常不可思议的剧本,就是《Django/Zorro》,我很希望Sony能搞定它,但我意识到这其中的不可能性。”卡迈克尔很可能指的是困扰创作者数十年的、围绕佐罗角色的复杂版权问题,即使在《卡普斯特拉诺的诅咒》于90年代进入公有领域之后也是如此。简而言之,一家声称持有佐罗版权的公司会起诉任何试图使用该角色的人;版权被细分到如此程度,以至于如果不向Zorro Productions Inc.支付许可费,即使不是不可能,也极难制作一部佐罗电影。2018年针对Zorro Inc.的一场诉讼可能改变了该角色的法律地位,或者Sony可能只是同意支付费用。(它有的是钱。)无论如何,侠盗风格正在卷土重来。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

52年前,一位作家创造了漫威有史以来最具争议的角色

Marvel Comics(SeaPRwire) -   当人们想到漫威漫画的成功,特别是20世纪60年代漫威与DC漫画呈现英雄方式的差异时,斯坦·李的名字会立刻被提及。当然,杰克·柯比也会被提到,因为正如我们所知,没有《神奇四侠》,就没有漫威的精髓。然而,还有许多漫画作家塑造了漫威在20世纪的遗产,其中或许最具影响力的创作者之一——格里·康威,现已去世,享年73岁。作为导致格温·史黛西死亡的臭名昭著的蜘蛛侠故事线的作者,以及DC角色杰森·托德的联合创造者,康威因许多事情而闻名。但他最长久的创作,无疑是漫威最硬核的刺客——弗兰克·卡索,又名惩罚者。康威在52年前,于《超凡蜘蛛侠》第129期中首次推出了惩罚者。自此,这个角色成为了漫画反英雄的终极典范。但康威是否意图让惩罚者代表一种无法无天的极端主义呢?简短的答案是否定的。乔恩·伯恩塔尔饰演惩罚者。| Netflix/Marvel/Disney+惩罚者最初被引入蜘蛛侠的世界时,是一种被另一个名为豺狼的恶棍操纵的赏金猎人。在某种意义上,惩罚者是漫威的波巴·费特,远在波巴·费特(或《星球大战》)出现之前。在2017年接受Inverse的埃里克·弗朗西斯科采访时,康威明确表示他最初并不认为这个角色会持续很久。“我以为这会是一个一次性、用完即弃的角色,但在开发过程中,随着我们深入挖掘角色和名字,很明显这是一个具有更大潜力的角色。”作为漫威最无情的反英雄之一,多年来对惩罚者的各种诠释各不相同。一些批评者指出,他代表了一种特定的枪支绝对主义者,并且是现实中无法无天的法西斯分子的某种象征。但这在很大程度上忽略了角色诞生时的社会现实。“那个时代是纽约市社会焦虑非常严重的时期……对此的一些反应就是私刑主义,”康威在2017年说道。但他同时也指出,他并不认为惩罚者是一个道德角色,相反,他说这个角色的行为“往好了说也只是道德上很灵活”。康威还明确指出,这个角色从来就不是为了作为任何政治运动的象征,尤其是任何支持种族主义的团体。“白人至上主义者和纳粹分子接纳[惩罚者]这一事实,是一个悲剧性的误解,”康威告诉《Inverse》。“这是对角色的盗用,也是对现实的公然漠视。”今天,康威最著名的创作依然存在。乔恩·伯恩塔尔今年将两次饰演惩罚者:一次是在2026年5月12日Disney+的独立特别节目中,另一次则是在一个圆满的时刻——伯恩塔尔饰演的惩罚者还将于2026年7月31日出现在漫威最著名的“爬墙者”电影《蜘蛛侠:全新一日》中。康威或许已离我们而去,但他最大胆的创作所留下的遗产,却非常稳固。您现在可以在Disney+上观看《惩罚者》系列剧集。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

Netflix 前景看好的新怪奇物语衍生剧已续订第二季

Netflix(SeaPRwire) -   Stranger Things的故事或许已经结束——颠倒世界(Upside Down)永远消失了,显然,十一(Eleven)也一样——但这并不意味着Stranger Things作为一个系列IP就此终结。除了探索年轻亨利·克里尔(Henry Creel)起源的百老汇剧目《Stranger Things: The First Shadow》之外,还有新的动画衍生剧《Stranger Things: Tales from ‘85》。这部热门剧集的衍生动画《Tales from ‘85》设定在第二季和第三季之间,展现了霍金斯(Hawkins)小队的冬季活动,以及他们的新朋友尼基·巴克斯特(Nikki Baxter)——他们代课科学老师的朋克女儿。现在看来,我们将看到更多这样的中间故事,但这次会回溯到霍金斯小镇本身的起源。《Stranger Things: Tales from ‘85》里的小镇新成员尼基·巴克斯特(Nikki Baxter)将继续出演下一季。| Netflix在接受《The Hollywood Reporter》采访时,《Tales from ‘85》的节目统筹埃里克·罗布莱斯(Eric Robles)透露,该系列将在Netflix回归第二季。这一点在剧集本身中已有暗示:尼基和巴克斯特夫人搬入了一所房子,希望能更长久地留在霍金斯。我们知道他们最终必须离开,因为这两个角色都没有出现在《Stranger Things》第三季中,但至少我们将在春季看到另一季的冒险故事。《Tales from ‘85》上线后,被多次拿来与《Star Wars: The Clone Wars》作比较——后者也是一部中间时段的动画衍生剧,引入了一个活泼的新角色。在这次采访中,罗布莱斯认可了这种比较。“我所希望的,和戴夫·菲洛尼(Dave Filoni)的《Star Wars: The Clone Wars》所发生的情况非常相似。一开始,每个人都在说‘《The Clone Wars》?’然后突然之间,人们开始观看它,然后说‘等等’。他们给了它一个机会,然后就沉浸在《Star Wars》的世界里,理解到这些是他们自己独特的冒险。”《Stranger Things: Tales from ‘85》将从邪恶植物转向霍金斯的深层历史。| Netflix在第二季中,这些独特的冒险将带领霍金斯调查俱乐部回到比以往任何时候都更早的时期。罗布莱斯说:“第二季中,我们将更多地了解霍金斯的历史,以及这段历史对这些孩子意味着什么。关于霍金斯的整体建立,会有更多的传说(lore),其中很多都与你看到的最后一朵花绽放时所有碎片如何拼凑在一起有关。”虽然在《Stranger Things》的整个系列中我们看到了很多闪回,但从未回溯到如此早的时期。但这实际上将回答整个系列中最大的谜团之一:为什么这一切最初会发生在印第安纳州的一个小镇上?我们在《Stranger Things》第五季和《The First Shadow》中看到过一些暗示,但这个新赛季可能会永远改变我们对这部剧的看法。《Stranger Things: Tales from ‘85》现已在Netflix上线。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

The Fifth International Healthcare Week set for next month, to highlight Hong Kong’s position as medical technology and investment hub

HONG KONG, Apr 29, 2026 - (ACN Newswire via SeaPRwire.com) - The fifth edition of the International Healthcare Week, organised by the Hong Kong Trade Development Council (HKTDC), will be held in Hong Kong from 11 to 31 May. The two flagship events – the sixth Asia Summit on Global Health (ASGH), jointly organised by the Government of the Hong Kong Special Administrative Region and the HKTDC, and the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair), organised by the HKTDC and co-organised by the Hong Kong MedTech Association – serve as a comprehensive business platform covering the entire medical and healthcare industry chain, including technology R&D, investment matching, medical equipment manufacturing, medical products and services. The events will be held concurrently to maximise synergy at the Hong Kong Convention and Exhibition Centre in Wan Chai next month. The ASGH will take place on 11 and 12 May, while the Medical Fair will run from 11 to 13 May.Sophia Chong, Executive Director of the HKTDC, said: “The medical and healthcare landscape is undergoing a profound and rapid transformation. Hong Kong, by leveraging its preeminence as an international financial centre, its world-class research ecosystem and its unique positioning bridging the Chinese Mainland and the world, serves as an ideal platform for scientific excellence, strategic investment and financing, and international trade for medical and healthcare innovation.The National 15th Five-Year Plan prioritises health development. The HKTDC will actively align with the Plan through the two flagship events of the International Healthcare Week – the ASGH and the Medical Fair. The events will focus on high-growth areas such as biopharmaceuticals, AI-empowered healthcare, the silver economy and modernisation of traditional Chinese medicine, and will help to accelerate  commercialisation of research outcome, facilitate high-impact business matching, and boost cross-border investment. Collectively, the twin events reinforce the ‘Healthy China’ initiative, solidify Hong Kong’s position as Asia’s leading biotech and investment hub, and demonstrate Hong Kong’s role as a superconnector and super value-adder.”Speaker line-up features Nobel Prize LaureateThe sixth ASGH, themed “Fuelling Healthcare Breakthroughs”, will convene a prestigious assembly of international health officials, scientific, medical and industry experts,  start-ups and investors. Through various sessions, they will exchange valuable insights and navigate the latest frontiers in public health, medtech, international trade and investment, while unlocking the future prospects and untapped business opportunities of the industry.The opening session will feature welcome remarks by Prof Frederick S Ma, Chairman of the HKTDC, and opening remarks by John Lee, the Chief Executive of the Hong Kong Special Administrative Region, followed by special remarks of Prof Zeng Yixin, Vice Minister of the National Health Commission of the People’s Republic of China.On the morning of the first day, two plenary sessions will be held. Plenary Session I: Strengthening Pandemic Preparedness through Global Collaboration will begin with a keynote speech by Prof Lo Chung-mau, Secretary of Health of the HKSAR government. The session will be moderated by Prof Leo Poon, Daniel CK Yu Professor in Virology at the School of Public Health of the University of Hong Kong and Co-Director of The Hong Kong Jockey Club Global Health Institute. Speakers include Prof Ibrahim Abubakar, Vice-Provost (Health) and Professor of Infectious Disease Epidemiology at University College London; Dr Leung Yiu-hong, Head of Emergency Response and Programme Management Branch, Department of Health; Dr Kumanan Rasanathan, Executive Director of the WHO Alliance for Health Policy and Systems Research; Prof Wang Yu, Chairman, Chinese Foundation for Hepatitis Prevention and Control, also Former Director-General, Chinese Center for Disease Control and Prevention; and Dr In-Kyu Yoon, Acting Deputy Director General for Integrated Development and Pandemic Preparedness at the International Vaccine Institute. They will delve into critical strategies such as pathogen surveillance, data sharing, multinational collaboration and equitable access to medical resources to bolster the resilience of global health infrastructure and institutionalise perpetual preparedness for potential future pandemics.Plenary Session II: Fuelling Healthcare Breakthroughs will examine how cross-sector collaboration catalyses the commercialisation of research outcomes, propels biopharmaceutical advancement, and unlocks investment and market potential in the sector. The session will feature a special address by Leng Weiqing, Chairman of Shanghai Industrial Investment (Holdings), the Strategic Partner of the Summit. It will be moderated by Victor Chu, Chairman and CEO of First Eastern Investment Group, with speakers including Jonathan Symonds, Chairman of the Board of GSK; Prof Song Ruilin, Eminent President and Chief Expert of the China Pharmaceutical Innovation and Research Development Association; Dr Mehmood Khan, CEO of The Hevolution Foundation; Clara Chan, Chief Executive Officer of Hong Kong Investment Corporation Limited; David Lau, Vice Chair of Investment Banking for Asia Pacific and Head of Healthcare Investment Banking for Asia Pacific at JP Morgan Securities; and Theresa Tse, Chairwoman of the Board, Sino Biopharmaceutical Limited.On the afternoon of the first day, the Dialogue with Global Pioneer in Health session will feature 2013 Nobel Prize Laureate in Chemistry, Prof Michael Levitt, Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University. Prof Levitt will share his distinguished journey in scientific discovery and envision the transformative impact of technology on future healthcare and scientific research. A pioneer in computational biology, he was among the first to simulate molecular dynamics of DNA and proteins. He was awarded the Nobel Prize for developing multiscale models of complex chemical systems.With rapid advances in AI drug discovery, oncology, and precision medicine, the summit introduces a dedicated CSO Insights: Catalysing Scientific Breakthroughs and Investments for Future Health session on the morning of the second day.  Chief Scientific Officers and R&D leaders from leading biotech and pharmaceutical companies, including Fosun Pharma, Omico, Zhaoke Ophthalmology, and more, will share how they set scientific strategy, build high-velocity, high-quality R&D engines, and forge partnerships that accelerate time-to-impact.Thematic sessions address market trends and the National 15th Five-Year PlanThe pervasive adoption of AI is driving a paradigm shift across industries, including healthcare. This year’s summit will feature two thematic sessions, including Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution, co-organised with Gleneagles Hospital Hong Kong, and Transforming Healthcare through Digital Health & AI Innovations. Speakers will examine pragmatic integration and pioneering breakthroughs of AI within the healthcare system.The silver economy represents a high-growth frontier. This year’s Summit will once again feature a dedicated Silver Health Chapter to address the complexities of an ageing demographic and unlock the sector’s burgeoning market potential. In the session Unlocking Growth in Silver Health: From Precision Medicine to Smart Ageing Innovations, distinguished speakers will discuss breakthroughs in the prevention, diagnosis and treatment of age-related diseases.In response to the National 15th Five-Year Plan, and to catalyse the Healthy China initiative and regional collaboration, the Summit will include a session titled The Next Frontier in China's Healthcare Industry which will review the latest trends in medical innovation and investment in China.The session Driving Chinese Medicine Development Through Standardisation and Innovation will  address the National 15th Five-Year Plan’s emphasis on the inheritance and innovation of traditional Chinese medicine. Speakers will share insight on traditional Chinese medicine innovation, cross-sector collaboration and regulatory matters.Over the two days, the Summit will cover a wide range of topical issues in the medical and healthcare sector, including sustainable healthcare systems, gene and cell therapy, rare disease treatments, medical robotics and devices, and IP financing strategies for pharmaceuticals and medtech.Supporting the expansion needs of medical/healthcare enterprisesIn addition to the plenary and thematic sessions, the Summit will feature the ASGH Business Hub and InnoHealth Showcase, which presents innovative technologies from some 180 medical and healthcare companies across 11 countries and regions. These include exhibitor delegations from Australia, Finland, the UK, Xiamen and Jiangsu, as well as start-ups and projects from the Innovation and Technology Commission, Cyberport, Hong Kong Science and Technology Parks, and five local universities. Many of the exhibitors have received prestigious awards. The Project Pitching session will provide start-ups with the opportunity to present their innovations to potential investors, while the ASGH Deal-making facilitates one-to-one meetings, both online and offline, to channel capital to healthcare projects and promote collaboration.Medical and healthcare enterprises can also access the “GoGlobal Connect” Zone and Business of Healthcare Advisory Zone to consult with service providers and institutions on overseas expansion, fundraising, R&D collaboration and other areas. Their professional advice will help companies formulate more effective business and “go global” strategies. The Summit will also host a workshop titled Hong Kong as a SuperConnector to Empower Global Expansion of Pharmaceutical Enterprises, where medical and business leaders will share how pharmaceutical companies can leverage Hong Kong’s platform and international professional services to seize overseas business opportunities.The Medical Fair’s three key categories: MedTech, GeronTech & Preventive HealthcareThe 17th Hong Kong International Medical and Healthcare Fair will be held from 11 to 13 May. Themed Innovations Boosting Smart Health Experience. The Fair will provide an ideal platform for research and development institutions, manufacturers, public healthcare organisations, hospitals, clinics, distributors, and healthcare professionals from around the world to establish global business connections and understand the latest trends in the medical industry. This year has seen a doubling in the number of exhibitors offering smart ageing products and green solutions, reflecting strong market demand for related products. Furthermore, several exhibitors will showcase innovative products and solutions integrating AI and robotic technology, offering buyers top-tier medical and healthcare solutions.The Medical Fair will gather some 300 exhibitors from 10 countries and regions, including Hong Kong, the Chinese Mainland, Taiwan, Korea, as well as new participants from Macao, Australia, Canada, New Zealand, Vietnam, and the United States. The exhibition will feature seven major zones, including the Startup Zone, Hospital Equipment and Digital Health, Biotechnology and Lab Diagnostics, Laboratory Technologies and Healthcare Services, Medical Supplies and Disposables, Rehabilitation and Elderly Care, and the World of Health and Wellness, showcasing the latest medical technologies and innovative solutions across the sector.The Fair will focus on three key areas: MedTech, GeronTech and Preventive Healthcare, presenting breakthrough technologies and products. Among the highlights, an exhibitor will introduce a smart health wearable watch that integrates concepts from both Chinese and Western medicine. By combining modern biosensing technology with traditional Chinese medicine theories and analysing indicators such as heart rate variability (HRV) to assess the functions of the five major internal organs, the device translates complex physiological data into a clear and easy-to-understand daily health score and personalised recommendations, helping users identify potential health risks at an early stage.Another exhibitor will demonstrate an augmented reality (AR) surgical platform designed for orthopaedic surgeons. The technology has already been applied in local hospitals and provides real-time 3D navigation during surgical procedures. By accurately overlaying medical imaging onto the surgical field, the platform enhances surgical precision and improves clinical decision-making efficiency. The technology was recognised with an award at the 2025 EQT Impact Challenge, where the project emerged as a winner after multiple rounds of selection and evaluation by a professional judging panel. The international startup competition aims to identify and support innovative solutions with positive social impact, underscoring the platform’s technological innovation and medical application value.In addition, an exhibitor will present a world-first smart knee brace that integrates artificial intelligence, wearable technology and rehabilitation applications. Designed for use in healthcare institutions such as wellness centres, hospitals and rehabilitation clinics, the product supports post-knee surgery recovery and sports injury rehabilitation. Through adjustable straps and a mobile application, the non-invasive device enables real-time monitoring of joint angles, thigh circumference and swelling changes during daily activities, rehabilitation therapy and training. It provides healthcare professionals with both real-time and historical data insights, enhancing the accuracy of rehabilitation monitoring, while also aiding injury prevention and extending athletes’ professional careers.The Medical Fair actively promotes collaborative innovation across government, industry, academia, research, and investment. A number of leading research and academic institutions will participate, including nine local universities, over 30 innovation and technology enterprises led by Hong Kong Science and Technology Parks, as well as some 20 medical enterprises brought by the Hong Kong MedTech Association (HKMTA). A startup will showcase innovative voice assistive technology products featuring a one touch speech reconstruction function. The solutions provide personalised support for individuals with speech and communication difficulties, helping them regain clear communication abilities and improve their quality of life. This innovation highlights the application excellence of local startups in both medical technology and social care, demonstrating how technology can address real societal needs with meaningful impact.More than 50 themed forums and seminars will be held during the fair, providing industry players with insights into the latest market trends. Highlights include “Accelerating Mental Health Innovation through AI Research and Adoption”, in association with Tung Wah College; “Decoding the Demand for Gerontechnology”, in association with the Hong Kong Council of Social Service; and the “HKMTA Medical Fair Forum 2026: The Medtech Solutions - Greater Bay Area & Overseas”, which will discuss the latest developments in the field.The exhibition will continue to adopt the “EXHIBITION+” hybrid model. The physical fair will take place from 11 to 13 May at the HKCEC. Global exhibitors, industry professionals, and buyers can engage in discussions via the “Click2Match” smart business matching platform from 4 May until 20.As the two flagship events of International Healthcare Week, the Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair will gather global healthcare forces to create a cross-sector exchange platform. International Healthcare Week will be held in Hong Kong from 11 to 31 May, covering 17 healthcare-related conferences, seminars, roundtables, and networking activities. It aims to promote innovation and investment exchange in the Asian healthcare industry, further creating industry synergies and driving Hong Kong's development as a regional medical innovation hub.The Asia Summit on Global HealthDate11-12 May 2026 (Monday to Tuesday)9:00am to 6:00pmThe Opening Session will begin at 10:00 am on 11 MayVenueHong Kong Convention and Exhibition Centre (HKCEC) Hall 3FGHong Kong International Medical and Healthcare FairDate11-12 May 2026 (Monday to Tuesday)10:00am to 6:00pm13 May 2026 (Wednesday)10:00am to 5:00pmVenueHong Kong Convention and Exhibition Centre (HKCEC) Hall 3DEPhoto download: https://bit.ly/48tQH4B Last year's Asia Summit on Global Health.The Asia Summit on Global Health has invited Prof Michael Levitt, 2013 Nobel Laureate in Chemistry, and the Robert W. and Vivian K. Cahill Professor in Cancer Research at the Stanford University School of Medicine, to attend and share his insights.The Asia Summit on Global Health features deal-making sessions, facilitating one-on-one meetings both online and offline to connect global capital with projects in the healthcare sector.The 17th Hong Kong International Medical and Healthcare Fair will be held from 11 to 13 May. Themed “Innovations Boosting Smart Health Experience” the fair focuses on three key categories: MedTech, GeronTech, and Preventive Healthcare, bringing together some 300 exhibitors from 10 countries and regions. The photo shows last year's Medical Fair.The Medical Fair has actively promoted collaborative innovation across government, industry, academia, research and investment, with a number of leading research and academic institutions set to participate.Many exhibitors will showcase products leveraging the latest artificial intelligence and robotics technologies, offering buyers cutting-edge medical and healthcare solutions. The photo shows last year's Medical Fair.WebsitesThe Asia Summit on Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en'ref_source=GrayMenu&ref_medium=vep-conferenceProgramme: https://www.asiasummitglobalhealth.com/conference/asgh/en/programme'ref_source=GrayMenu&ref_medium=vep-conferenceSpeakers: https://www.asiasummitglobalhealth.com/conference/asgh/en/speaker'ref_source=GrayMenu&ref_medium=vep-conferenceHong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/en'ref_source=GrayMenu&ref_medium=vep-tradeshowList of Products: https://www.hktdc.com/event/hkmedicalfair/en/product'ref_source=GrayMenu&ref_medium=vep-tradeshowActivity Schedule: https://www.hktdc.com/event/hkmedicalfair/en/programme'ref_source=GrayMenu&ref_medium=vep-tradeshowInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enMembers of the media interested in interviewing ASGH speakers, please send requests to  lsong@yuantung.com.hk or tleung@yuantung.com.hk on or before 4 May 2026.Media enquiriesYuan Tung Financial Relations:Jasmine Zhang  Tel: (852) 3428 3278  Email: jzhang@yuantung.com.hkLouise Song  Tel: (852) 3428 5691  Email: lsong@yuantung.com.hkTiffany Leung  Tel: (852) 3428 2361  Email: tleung@yuantung.com.hkHKTDC Communications & Public Affairs Department:Noah Qiu  Tel: (852) 2584 4575  Email: noah.yl.qiu@hktdc.orgNavin Law  Tel: (852) 2584 4525 Email: navin.cm.law@hktdc.orgJane Cheung  Tel: (852) 2584 4137  Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

我们所知道的关于Resident Evil重启的全部信息

Monica Schipper/Getty Images Entertainment/Getty Images(SeaPRwire) -   虽然改编并不一定能证明或提升一部艺术作品的价值,但好莱坞已经三次尝试将《生化危机》系列搬上真人银幕,却都以失败告终,这或许是对该系列持久生命力和文化共鸣的最佳证明。保罗·W·S·安德森、安德鲁·达博和约翰内斯·罗伯茨都以各自的方式诠释了这部备受喜爱的僵尸系列,但都因种种原因遭到了评论家和粉丝的否定。部分原因在于他们拒绝直接改编游戏的剧情(这本身有利有弊),部分原因也在于这三部作品都没有聚焦于那种逐渐蔓延的恐惧和求生的绝望感,而这正是最初几款游戏如此令人不寒而栗的原因。然而,这种情况最终可能即将改变,因为下一次《生化危机》回归影院,将出自一位新兴的恐怖片新秀之手。扎克·克雷格仅凭两部电影,就已经成为当代该类型的佼佼者,而且他的电影在风格和子类型上差异巨大。他的第一部恐怖片《野蛮人》是对70年代托比·胡珀式剥削电影的致敬,并带有社会评论的暗流;而他的第二部电影《武器》则是一部基调更阴郁、主题更难以捉摸的女巫电影。如果说有谁能重现原版《生化危机》三部曲那种令人窒息的恐怖感,那可能就是他。幸运的是,我们无需等待太久就能看到他对浣熊市的构想。《生化危机》何时上映?正好赶上万圣节季的开始,《生化危机》计划的上映日期是2026年9月18日。希望克雷格能重现浣熊市事件中的孤立感、混乱和纯粹的恐怖。| Capcom《生化危机》的剧情是什么?尽管有11部主线游戏发行和7部真人改编作品(其中6部创作了独立的故事),但《生化危机》的总体叙事是相当知名的:国际制药公司Umbrella Corporation暗地里是一家生物有机武器制造商,他们的最新创造——T病毒,能将生物体变成肆虐横行的 grotesque monstrosities。在游戏中,玩家扮演不同的幸存者(从遭遇厄运的特种警察部队STARS的克里斯·雷德菲尔德和吉尔·瓦伦丁,到从菜鸟警察转变为特种部队万人迷的里昂·S·肯尼迪),每个人都试图挫败Umbrella Corporation,阻止他们释放到世界上的任何噩梦般的实验——当然,前提是他们能活下来。尽管克雷格确认他即将上映的电影将借鉴并围绕《生化危机2》和《生化危机3:复仇女神》展开,但它不会直接改编这些游戏。虽然我们对克雷格的原创故事细节知之甚少,但我们知道这部电影将跟随一名名叫布莱恩的医疗快递员,他发现自己被困在浣熊市,“一个宿命般、恐怖的夜晚在混乱中降临到他周围。”可以合理地推测,我们与布莱恩共度的那个夜晚将是导致浣熊市在《生化危机2》中被隔离的灾难性病毒爆发事件,粉丝们将从一个不同的视角看到这个定义了该系列未来十年的事件。尽管《生化危机2》已经很恐怖了,但想象一下对于一个手无寸铁的普通人来说会有多糟糕。| Capcom有《生化危机》的预告片吗?还没有,但一旦预告片发布,我们将在此页面更新链接和更多剧情细节。《生化危机》的演员阵容有哪些人?克雷格的《生化危机》似乎不会像保罗·W·S·安德森或约翰内斯·罗伯茨的电影那样拥有庞大的群星阵容。相反,这部电影似乎将侧重于让观众沉浸于布莱恩的旅程中,让观众从一个最终陷入恐怖境地的普通人的单一、实地视角来体验浣熊市的爆发。《生化危机》已确认的演员包括:奥斯汀·艾布拉姆斯 饰演 布莱恩保罗·沃尔特·豪泽 饰演 卡尔扎克·切里 饰演 戴夫卡莉·瑞斯 饰演 波琳约翰诺·威尔逊 饰演 麦克斯目前尚不清楚这些角色在布莱恩的旅程中会扮演多大的角色,但如果这部电影真的想要唤起游戏中的无情和震撼,那么他们中的许多人恐怕都活不长。扎克·克雷格擅长创作不可预测、令人神经紧绷、让人指缝观瞧的电影,如果早期报道属实,这部新片将和他前两部作品一样恐怖,节奏高能,全程无尿点。它是否能满足该系列的长期粉丝还很难判断,但也许我们终于可以相信,《生化危机》至少会像其原作一样吓人。《生化危机》将于9月18日登陆影院。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

12年后,星球大战让其最被低估的反派再次变得恐怖

Lucasfilm(SeaPRwire) -   《摩尔:暗影之主》(Maul — Shadow Lord)让我们重新审视了这位曾被称为达斯·摩尔(Darth Maul)的反英雄。在被剥夺了“达斯”头衔后,他现在只是一个卑微的犯罪头目,试图建立一个帝国,并可能将年轻的学徒德文·伊扎拉(Devon Izara)带向黑暗面。但如果他不是这部剧的反派,那谁才是呢?答案一如既往,是帝国。布兰德·劳森(Brander Lawson)正试图在不惊动帝国的情况下追踪摩尔,但尽管如此,当权者还是派出了判官(Inquisitors)去追踪摩尔以及躲藏在杰尼克斯(Janix)上的两名绝地武士。这是帝国的惯用伎俩,但这次有点不同。这一次,这些低级别的反派看起来比以前更加令人不安。马罗克(Marrok)和第十一兄弟被帝国派往杰尼克斯。 | Lucasfilm在目前的《星球大战》正史中,当绝地武士在“66号指令”后四处躲藏时,正是判官在追捕他们。判官形态各异,但他们通常都有某种代号,往往包含“兄弟”或“姐妹”等字眼。判官最初在《星球大战:义军崛起》(Star Wars: Rebels)中引入,其本质是为该剧的主角们提供一个既能被击败又不会干扰《星球大战》正史的反派。最初,在“传说”(Legends)正史中,铲除在“66号指令”中幸存的绝地武士似乎是达斯·维达(Darth Vader)唯一的任务,但在新的正史中,他更多地扮演着判官首领的军官角色。例如,在电子游戏《星球大战 绝地:陨落的武士团》(Jedi: Fallen Order)中,主角卡尔·凯斯蒂斯(Cal Kestis)是一名在“66号指令”多年后隐居的绝地武士,他必须先击败多名判官,然后才能面对达斯·维达本人。有了这种等级制度,人们很容易将判官视为较小的威胁。是的,他们戴着阴森的面具,是的,他们拥有花哨的光剑,但他们之所以出现,仅仅是因为维达认为目标不值得他亲自出马。第十一兄弟在内部被昵称为“乌鸦”(The Crow)。 | Lucasfilm然而,《摩尔:暗影之主》彻底重塑了判官的形象。由于前几集的铺垫,当马罗克(Marrok)和第十一兄弟最终出现时,感觉他们就像是纯粹的原创反派,尽管他们此前分别在《阿索卡》(Ahsoka)和《绝地传奇》(Tales of the Jedi)中出现过。助力这一新形象的是对这些角色采用的恐怖电影处理方式。根据《星球大战》官网的说法,“他们动作不多,但一旦行动,这些判官就拥有超人的速度,”网站写道。“当第十一兄弟转头时,请仔细听。‘在后期的混音中,David W. Collins 总是会加入一些奇怪的东西,’执行导演 Brad Rau 说道。‘当你听到‘乌鸦’转头的一点声音时,Collins 加入了这种吱吱作响的怪声。这太棒了。我们称之为‘骨皮声’(bone leather)。’”此前,判官在某种程度上充当了达斯·维达登场的序曲或低风险替代品。对于这部剧来说,这并非不可能——在5月4日(原力日)播出的结局中让维达现身,这个诱惑实在太大了——但这次大规模的铺垫和对这些角色的新处理方式证明,他们完全可以独当一面。《星球大战:摩尔 — 暗影之主》现已在 Disney+ 上线。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

CTF Life Title Sponsors ‘Fencing Plus’ Training Programme 2026 Organised by Kai Tak Sports Initiative

(Second from left) Man Kit Ip, Executive Director and CEO of CTF Life; (second from right) Andrew Kam, Chief Executive Officer of Kai Tak Sports Park Limited; (first from left) NG Hoi-shan, Aaron, MH, President of the Fencing Association of Hong Kong, China; and (first from right) Antonio Lam, Head Coach of the “Fencing Plus” Training Programme, officiated the Kick-off Ceremony of the “Fencing Plus” Training Programme, marking the official start of the event.HONG KONG, Apr 29, 2026 - (ACN Newswire via SeaPRwire.com) - The “Fencing Plus” Training Programme, organised by Kai Tak Sports Initiative (KTSI), title-sponsored by CTF Life and supported by Kai Tak Sports Park (KTSP), is Hong Kong’s largest fencing selection and training initiative aimed at nurturing a new generation of fencing athletes in Hong Kong. Since its debut at KTSP last year, the programme has identified numerous promising young fencers, providing them with 1.5 years of elite training and injecting fresh energy into the local fencing scene. With CTF Life once again serving as the Title Sponsor this year, the programme’s selection quota has expanded to 1,000 participants, offering more students the opportunity to receive professional training. Former Olympic Games representative of the Hong Kong Fencing Team and Asian Games Double Bronze Medallist, Antonio Lam returns as Head Coach, leading a professional coaching team to ensure high-quality and consistent training.The Selection Day and Kick-off Ceremony of the “Fencing Plus” Training Programme 2026 were successfully held on 26 April at Kai Tak Arena. Building on the enthusiastic response received last year, the 1,000 available slots include dedicated quotas for CTF Life-CIRCLE members, while full sponsorship will continue to be offered to underprivileged students. Primary school students aged 8 to 11 from Kowloon City, Kwun Tong, Wong Tai Sin and Yau Tsim Mong districts were invited to take part, giving more children the opportunity to be introduced to the sport. The two-year training programme is structured into five stages, using a selection-based training and competition model to identify potential young fencers. Top performers will advance to elite training with opportunities to progress into professional athlete development and participate in competitions. The selection trials featured 10 fencing test zones, allowing participants to challenge themselves through physical fitness assessments and discover their potential. CTF Life also introduced a series of interactive experience zones, including the “Strike & Score Fencing Game”, the “Fencing Collection Card Photo Booth,” and the “AR 360-degree Fencing Champion Stage”, encouraging parents and children to take part in sports together and experience the unique charm of fencing.Honourable guests – Man Kit Ip, Executive Director and CEO of CTF Life; Andrew Kam, Chief Executive Officer of Kai Tak Sports Park Limited; NG Hoi-shan, Aaron, MH, President of the Fencing Association of Hong Kong, China; and Antonio Lam, Head Coach of the “Fencing Plus” Training Programme – also attended the event and officiated the Kick-off Ceremony.Man Kit Ip, Executive Director and CEO of CTF Life, said: “As the exclusive Founding Insurance Partner of KTSP, and in celebration of CTF Life’s 40th anniversary, we are delighted to once again serve as the Title Sponsor of KTSI’s ‘Fencing Plus’ Training Programme. Through this sponsorship, we are supporting the HKSAR Government to promote local sports development and nurture a new generation of elite fencing athletes. At the same time, by reserving dedicated places for CTF Life-CIRCLE members, we are delivering premium experiences to our customers and reaffirming our brand promise to create value beyond insurance.”Andrew Kam, Chief Executive Officer of Kai Tak Sports Park Limited, said: “The ‘Fencing Plus’ Training Programme is the most extensive fencing training initiative in Hong Kong. We are sincerely grateful to CTF Life for sponsoring the programme for the second consecutive year. Looking ahead, Kai Tak Sports Park will continue to collaborate with diverse partners through Kai Tak Sports Initiative, leveraging our world-class facilities to drive impactful sports projects and cultivate the next generation of Hong Kong sporting talent.”The ceremony concluded with a symbolic sabre presentation, attended by the 20 “Fencing Plus” participants who advanced to the final stage of last year’s programme. Together with Antonio Lam, Head Coach of the “Fencing Plus” Training Programme, Low Ho Tin, Bronze Medallist in Men’s Sabre at the 2018 Asian Games, and Yip Shing Chi, Bronze Medallist in the Cadet Men’s Sabre Individual event at the Asian Cadet Fencing Championships 2026, presented sabres to last year’s finalists, symbolising the passing on of the torch and encouraging the new cohort to pursue their fencing journey with determination as Hong Kong’s future fencing talent.Man Kit Ip, Executive Director and CEO of CTF Life, said: “As the exclusive Founding Insurance Partner of KTSP, and in celebration of CTF Life’s 40th anniversary, we are delighted to once again serve as the Title Sponsor of KTSI’s ‘Fencing Plus’ Training Programme, underscoring our brand promise to create value beyond insurance.”Andrew Kam, Chief Executive Officer of Kai Tak Sports Park Limited, said: “Kai Tak Sports Park will continue to collaborate with diverse partners through Kai Tak Sports Initiative, to drive impactful sports projects and cultivate the next generation of Hong Kong sporting talent.”The Selection Day of the Kai Tak Sports Initiative “Fencing Plus” Training Programme 2026 was held on 26 April. The event invited over 1,000 children to take part in a series of dynamic fitness assessments designed to identify potential young fencers!CTF Life introduced a series of interactive experience zones, encouraging parents and children to take part in sports together and experience the unique charm of fencing.Click here to download high-resolution photos.About CTF LifeChow Tai Fook Life Insurance Company Limited (“CTF Life”) is proud of its rich, 40-year legacy in Hong Kong. CTF Life is a wholly-owned subsidiary of CTF Services Limited (“CTFS”) (Hong Kong Stock Code: 659) and is one of the most well-established life insurance companies in Hong Kong. As a member of Chow Tai Fook Enterprises Limited, CTF Life consistently strengthens its collaboration with the Chow Tai Fook Group ecosystem to support customers and their loved ones in navigating life’s journey with personalised planning solutions, lifelong protection and diverse lifestyle experiences. By leveraging the Group’s robust financial strength and strategic investments across the globe, CTF Life aspires to become a leading insurance company in Asia while continuously creating value beyond insurance.About Kai Tak Sports ParkKai Tak Sports Park is the largest integrated sports, leisure, and entertainment landmark in Hong Kong. The 28-hectare Sports Park is part of the redevelopment of the former Hong Kong International Airport site in Kai Tak. The precinct features the 50,000-seat Kai Tak Stadium, which has a retractable roof; the Kai Tak Arena, an indoor sports center with the flexibility to host community sports and events for up to 10,000 seats; and the Kai Tak Youth Sports Ground, an outdoor track and field facility with a capacity of 5,000 seats. These venues are complemented with extensive open spaces for events and leisure, together with dedicated retail and harbourfront dining spaces.About Kai Tak Sports InitiativeAs a community project of Kai Tak Sports Park and a locally recognized charitable organisation, Flyover Kai Tak has been committed to organising various sports activities in the community to encourage public participation and promote sports for all. Since its establishment in 2018, Fly Over Kai Tak has launched 180 projects with more than 100 partners, attracting about 125,000 participants. With the official opening of the Kai Tak Sports Park in March 2025, Flyover Kai Tak will launch more exciting activities in the park, allowing the public to continue to participate in different ways to enhance their physical and mental health. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

周大福人寿冠名贊助:飞越启德「小剑神」培训计划2026

周大福人寿执行董事兼行政总裁叶文杰先生(左二)、中国香港剑击总会会长伍海山先生(左一)、启德体育园有限公司行政总裁金民豪先生(右二)及「小剑神」培训计划总教练林衍聪先生(右一)莅临主持「小剑神」培训计划启动礼,为活动揭开序幕。香港, 2026年4月29日 - (亚太商讯 via SeaPRwire.com) - 由飞越启德主办、周大福人寿冠名贊助、启德体育园全力支持的「小剑神」培训计划,是全港最大规模的剑击选拔及培训活动,旨在培育香港新一代剑击运动员。计划去年首度于启德体育园举行,成功发掘多位具潜质的年轻剑手,并为他们提供为期一年半的高阶训练,为香港剑坛注入新力量。而计划今年再度获周大福人寿冠名贊助,参加名额更增加至 1,000 个,让更多学童有机会接受专业剑击训练。计划继续邀请香港前剑击队佩剑奥运代表、亚运会双铜牌得主林衍聪出任总教练,率领教练团队提供专业指导,确保培训质素及延续性。「小剑神」培训计划2026首阶段的遴选日暨启动礼于4月26日假启德体艺馆圆满举行。承接上年度的活动反应热烈,今届1,000 个名额中包括周大福人寿.生活圈会员,同时继续为基层学生提供全额资助,邀请来自九龙城区、观塘区、黄大仙区及油尖旺区的8至11岁小学生参与,让更多学童有机会接触剑击运动。为期两年的训练分为五个阶段,採用淘汰制训练及比赛模式,发掘具潜质的小剑神。表现出色的学员将获晋升至进阶训练,并有机会衔接本港专业运动员的培训及参赛计划。选拔赛设有十项剑击测试专区,让参加者进行体能测试,挑战自我,发掘潜能。周大福人寿亦特别增设互动体验专区,包括「空中撃剑挑战」、「剑撃收藏卡照相馆」及「AR 360度撃剑冠军舞台」,鼓励家长与孩子一起投入运动热情,亲身感受剑击运动的独特魅力。活动非常荣幸邀请到周大福人寿执行董事兼行政总裁叶文杰先生、启德体育园有限公司行政总裁金民豪先生、中国香港剑击总会会长伍海山先生及「小剑神」培训计划总教练林衍聪先生莅临主持启动礼,为活动揭开序幕。周大福人寿执行董事兼行政总裁叶文杰先生致辞时表示:「作为启德体育园的独家创始保险合作伙伴,适逢周大福人寿40周年誌庆,我们很高兴再度冠名贊助飞越启德『小剑神』培训计划,支持特区政府推动本地体育发展和培育新一代剑撃精英运动员,亦透过周大福人寿‧生活圈会员尊属名额,为客户带来优质体验,继续彰显开创保险新价值。」启德体育园有限公司行政总裁金民豪先生致辞中分享:「『小剑神』培训计划是全港最大规模的剑击培训活动,衷心感谢周大福人寿连续第二届贊助此计划。未来启德体育园将继续透过飞越启德,与更多伙伴携手合作,善用园区世界级设施,推动更多具影响力的体育项目,为香港培育新一代运动人才!」启动礼最后环节举行授剑仪式,邀请上届晋身最后阶段的20位「小剑神」出席,由「小剑神」培训计划总教练林衍聪先生联同2018年亚运男子佩剑铜牌得主罗浩天先生,以及2026亚洲青少年剑击锦标赛少年组男子佩剑个人赛铜牌得主叶诚治先生,共同为「小剑神」授剑,寓意薪火相传,同时勉励新一届学员在剑击路上奋勇前行,成为香港未来的剑击新力量。周大福人寿执行董事兼行政总裁叶文杰先生表示,作为启德体育园的独家创始保险合作伙伴,适逢周大福人寿40周年誌庆,再度冠名贊助「小剑神」计划,彰显其开创保险新价值的品牌承诺。启德体育园有限公司行政总裁金民豪先生分享,启德体育园将继续透过飞越启德,与更多伙伴携手合作推动更多具影响力的体育项目,为香港培育新一代运动人才!飞越启德「小剑神」培训计划2026 年4月26日举行遴选日,邀请多达1,000位小朋友参加,透过体能测试发掘具潜质的小剑神!周大福人寿特设互动体验,让家长和孩子一起享受参与剑击的乐趣。按此下载高清相片关于周大福人寿周大福人寿保险有限公司(「周大福人寿」)扎根香港40年,为周大福创建集团有限公司(「周大福创建」)(香港股份代号:659)的全资附属公司,也是香港最具规模的寿险公司之一。作为周大福企业成员,周大福人寿紧扣郑氏家族(「周大福集团」或「集团」)生态圈的雄厚资源,致力为客户及其挚爱家人于「生活、成长、健康、传承」的人生旅程中,提供个人化的匠心规划、终身保障及优质体验。凭藉集团财务实力及环球投资布局,周大福人寿矢志成为亚太区领先的保险公司,持续开创保险新价值。关于启德体育园启德体育园是香港的大型综合体育及休闲娱乐新地标,佔地28公顷,是昔日启德机场旧址重新发展计划的一部份。园区主要设施包括一个设有50,000万个座位,并配备开合式上盖的全天候主场馆(「启德主场馆」);一个可灵活配置座位的室内体育馆(「启德体艺馆」),其主场(「竞技场」)可容纳10,000名观众,而副场(「习艺坊」)可容纳500名观众;以及一个设有5,000个座位的公众运动场(「启德青年运动场」)。除此之外,园区内亦设有大量户外空间、餐饮零售设施和美食海湾,让各个场地的体育及娱乐盛事更添精彩。关于飞越启德作为启德体育园的社区项目及本地认可的慈善机构,飞越启德一直致力在社区举办各类型的体育活动,鼓励市民踊跃参与,推广全民运动。于2018年成立至今,飞越启德已联同超过100个合作伙伴,推出多达180个项目,吸引约125,000人次参加。随着启德体育园于2025年3月正式落成启用,飞越启德将会在园区推出更多精彩活动,让市民能够继续以不同方式参与,提升他们的身心健康。周大福人寿保险有限公司(于百慕达註册成立之有限公司) Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

AI智能体元年启动  迈越科技(2501.HK)深耕东盟市场开启价值重估

EQS via SeaPRwire.com / 2026-04-29 / 09:27 UTC+8 2025年被公认为人工智能从概念迈向规模化应用的关键转折点。港股人工智能应用端领先企业 - 迈越科技股份有限公司(「迈越科技」,股份代号:2501.HK)于3月份发布2025年度业绩,财报显示,公司在人工智能赛道实现了跨越式增长:全年实现营收约人民币4.03亿元,同比增长46.6%;年度溢利高达人民币544.3万元,较去年同期大增约5,300%。 这份亮丽的成绩表,不仅体现了迈越科技在「人工智能+」行动中的强大执行力,更预示着其在即将到来的「AI智能体(AI Agent)元年」中占据了甚具竞争力的领先地位。 业绩爆发:软硬件协同打造盈利新空间 中国国家及地方政策为人工智能发展指明方向:国务院《关于深入实施“人工智能+”行动的意见》、《广西深入实施“人工智能+”三年行动方案(2026—2028年)》及“北上广研发+广西集成+东盟应用”发展路径,都明确指出人工智能为国家的未来重点发展方向之一,这为迈越科技的战略布局提供清晰指引。 迈越科技业绩的强劲增长,主要归功于客户对综合IT解决方案服务需求的日益增长。2025财年,该板块贡献收入约2.98亿元,同比增长59%。 公司在提升人工智能应用方面展现了卓越的技术底蕴: 在技术创新方面,深度适配DeepSeek、千问等国产大模型,同时兼容GPT、Gemini、Claude Opus等国外先进大模型,融合openclaw等前沿技术,自主研发AI智慧体平台,突破多模态交互、算力调度、数据安全等关键技术,构建自主知识体系。 产品创新上,公司从软件延伸至智能算力一体机、AR眼镜、翻译硬件等,实现软硬件一体化、场景一体化。场景创新上,坚持把AI用到真实场景、解决真实问题。AI问数助手降低数据分析门坎,AI智能写作助手提升办公效率,AI数字人应用于政务、教育、客服等领域,让创新真正创造价值。 迈越科技表示,公司正积极探索以「AI 智能体」技术为核心,结合 AR 眼镜、全息投影舱等交互硬件,构建面向智慧农业、工业巡检、智慧文旅及心理健康陪伴的沉浸式智能化服务场景。这种「智能体+场景」的深度渗透,正持续打开公司的利润增长空间。 战略布局:立足广西,辐射东盟「数字丝路」 国内外人工智能应用呈爆发式增长。在发展潜力上,智能教育、数字政务、工业制造等领域仍有巨大渗透空间,东盟国家人工智能尚处起步阶段,市场空白且广阔。 作为广西互联网综合实力十强企业,迈越科技充分利用「自主研发+广西集成+东盟应用」的发展路径,成功将科技力量辐射至东盟国家。 2026年4月17日,越共中央总书记、国家主席苏林率高级代表团参观了位于中国南宁的东盟人工智能创新合作中心。该中心是推动中国企业深入挖掘东盟潜力的重要门户,一期工程相关项目面积约7.78平方公里,中心建筑面积达1.9万平方米。 在参观过程中,苏林总书记、国家主席亲自试戴并深度体验了由迈越科技研发的 AI 翻译眼镜。这一领袖级的亲身体验,不仅展示了迈越科技在区域语言解析与穿戴设备领域的领先实力,也预示着中国AI产品在越南等东盟市场的巨大增长潜力。 4月17日,越共中央总书记、国家主席苏林在中国—东盟国家人工智能应用合作中心试戴迈越AI翻译提词眼镜,右一为迈越科技董事长李常青先生。   关于迈越科技股份有限公司(股份代号:2501.HK)迈越科技是领先的综合IT解决方案服务供货商,致力于将AI、大数据及云计算技术深度融入行业应用。公司深耕智能教育、数字政务及智能穿戴设备领域,旨在构建「立足广西、辐射全国、面向东盟」的AI产业新高地。   2026-04-29 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

德银351港元目标价背后:迅策(03317)ARR环比大涨300%

EQS via SeaPRwire.com / 2026-04-29 / 09:13 UTC+8 4月27日,德意志银行发布了一份关于迅策科技(03317)的研究报告。该行将目标价定为351港元,较市价有超20%的上行空间,并维持“买入”评级。   自2016年成立至今,迅策科技共完成7轮融资,股东包括腾讯、KKR、云锋基金、泰康人寿、浦发银行等。从A轮至今,估值已涨超530倍。对于这些陪跑近十年的股东而言,这无疑是一场酣畅淋漓的胜利。   然而,这些顶级机构押注的远不止是一家公司,而是一个正在加速成型的大趋势——Token经济。   Token经济模式的核心,是将收费基础从“软件使用权限”转变为“价值消耗单位”。在传统SaaS模式下,客户支付固定订阅费,供应商的收入与客户实际使用价值没有直接关联。而在Token模式下,客户按实际消耗量付费——用得越多、创造价值越高,供应商的收入弹性越大。   随着AI Agent的演进,Token需求将呈指数级增长。据弗若斯特沙利文统计,中国实时数据基础设施与分析市场2024年规模为187亿元,渗透率仅3.6%,到2029年预计达505亿元,年复合增速22%。在这样一个渗透率极低、需求快速释放的市场中,迅策在AI实时数据基础设施市场中排名头部。   在这一趋势中,迅策扮演了什么角色?德银给出的答案是“数据燃料供应商”和“计费枢纽”。前者指向其在AI产业链中的定位:区别于提供通用大语言模型的厂商,迅策聚焦于垂直领域,通过领域特定的数据专业知识,帮助企业生成高精度、高决策价值的数据。后者指向其商业模式的核心:在每一次AI调用中完成计量与结算,成为Token经济时代的“收费站”。   德银指出,这种垂直化的“Token即服务”(TaaS)模式使迅策能够获得稀缺溢价,收入与通用计算成本脱钩,随客户工作流的扩展实现非线性增长。在定价机制上,迅策正在从三个维度构建其Token定价体系:数据稀缺性、调用频率、模块化扩展能力。   迅策目前主要有三种收费模式:传统订阅制、交易制,以及正处于快速起量阶段的Token制。据公司管理层披露,Token模式目前收入占比约5%,目标在2026年底提升至20%-30%。进入2026年4月,迅策Token调用相关的年度经常性收入(ARR)季度环比暴涨300%。这一趋势表明,Token调用收入正成为迅策全新的增长引擎。   德银预计,随着这一转型推进,迅策经调整后的净利润率将在2025-2028年间从6.9%升至24.4%,营收复合增长率预测也从57%上调至76%。未来三年将是迅策盈利能力加速释放的关键窗口期。   迅策从资管行业切入,并逐步向保险、银行、能源、电信等对数据精确性和监管合规要求极高的领域延伸。在存量市场,迅策通过高转换成本持续锁定客户价值;在增量市场,迅策已覆盖金融、电信、电力、能源及消费等10余个行业,并且对标美国Palantir的17个垂直领域,增长空间仍然可观。   未来,迅策正加速向电力、电信、医疗、能源、机器人训练平台等国计民生重点领域拓展,2025年起更将AI基础设施延伸至机器人数据平台及商业航天等新兴赛道。   在AI时代,最赚钱的不是淘金者,而是卖铲子的人。但最稳赚的,是那些把铲子升级为“智能挖掘机”的人。迅策,正在成为后者。当Token成为AI世界的基础货币,当每一次模型调用都需要经过“计费枢纽”,迅策的收入便与整个AI产业的繁荣深度绑定。   2026-04-29 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

游客在豪华度假村去世,蛇类表演中一条从表演中逃出的科布拉爬上了他的裤子,咬了他:警方

(SeaPRwire) -   当局称,一名德国游客在观看蛇类表演时,一条毒眼镜蛇据称爬进了他的裤子并咬伤了他的腿部,该游客随后死亡。据德国巴伐利亚州警方周一公布的细节,这起离奇事故发生在四月初埃及的一个豪华度假胜地。官员们表示:"在耍蛇人表演期间,其中一条蛇爬进了一名57岁男子的裤子里,导致这名德国游客的腿部被咬伤。"警方称,受害者的身份尚未公布,当时他正与两名来自德国翁特阿尔高地区的家庭成员一起度假。当局表示,耍蛇人表演是红海热门度假胜地赫尔格达市酒店娱乐项目的一部分,该地以其高档的全包套餐以及附近的沙漠和水上短途旅行而闻名。官员称,表演中使用了据信是眼镜蛇的两条蛇。调查人员指出,表演者让蛇与观众成员近距离互动并不少见,据报道在表演过程中,有些蛇曾被放在客人的脖子上。然而,在表演的一个环节中,据报道一条蛇在爬进这名德国游客的衣服后咬了他。官员们说:"他随后出现了明显的中毒症状,需要进行心肺复苏。"据报道,他在抵达当地医院后不久便死亡。巴伐利亚警方表示,毒理学检查结果仍在等待中。调查由德国的梅明根刑事警察监察局在梅明根检察院(MPPO)的指导下进行。眼镜蛇是众所周知毒性极强的蛇类。被其咬伤后若未得到及时治疗,可迅速导致呼吸衰竭和瘫痪。Digital 已联系 MPPO 以获取更多信息。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

DCU的不太可能的超级英雄团队电影已被搁置

(SeaPRwire) -   在当今时代,电影制片厂和流媒体平台承诺过多却交付不足的情况并不罕见。以 Star Wars 在2020年关于其下一阶段电视项目的宏大公告为例:最终真正完成的项目仅占宣布项目的一小部分。有了这样的先例,粉丝们也学会了降低预期,以防出现变故导致计划落空。当 James Gunn 接任 DC Studios 联席总裁时,在“Gods and Monsters”这一宏大的章节名称下,也宣布了一系列类似的项目,类似于 Marvel 的“阶段”结构。最初的计划详细列出了五部电影和五部电视剧,虽然其中一些项目已经取得了成功,例如《Superman》和《Peacemaker》第二季,但仍有许多项目在筹备中。然而,其中一部计划中的电影已经完全停滞,Gunn 刚刚确认该项目已被无限期搁置。DC Studios 联席总裁 James Gunn 透露,一部已宣布的电影已被搁置。 | John Nacion/Variety/Getty Images在 Threads 上,一位粉丝对《The Authority》的进展表示好奇,这是2023年与《Superman》、《Supergirl》、《Clayface》和《Swamp Thing》一同宣布的电影之一。另一位粉丝推测 Gunn 会亲自编写剧本,这促使 Gunn 本人进行了回应。“我从来没有时间做这件事,尽管我知道这是一个在网上很流行的理论,但我从未打算编写或执导《The Authority》,”他写道。“剧本还不够完善,但更重要的是,从故事和实际操作层面来看,它并不适合更大的 DCU。也许有一天会实现。但不是近期。”The Authority 是一个反英雄超级小队,他们决心不惜一切代价完成任务,从不顾及道德或法律。2025年,Gunn 在一次新闻发布会上表示,在所有开发中的电影里,《The Authority》被证明是最困难的。“这既是因为整体故事的不断调整,也是因为在《The Boys》以及所有受《The Authority》影响且在其之后出现的作品所构成的世界中,要把它做好非常困难,”据 Gizmodo 报道,他说道。“而且我们还有很多已经拍摄完成、我们深爱并希望继续讲述其故事、并希望看到他们相互交集的人物。所以,我不得不承认,它目前被暂时搁置了。”The Authority 截然不同的准则可能无法与 DC Universe 的其余部分相融合 | DC Comics现在看来,曾经被搁置的项目已经被彻底移出日程,封存起来了。从大局来看,不难理解为什么这个项目会与其余的片单格格不入。这个新的 DCU 大部分建立在《Superman》所展现出的乐观和希望之上,而 The Authority 这个小队在道德上其实更接近 Thanos:为了达成最终目标,一切手段都是允许的。但情况也并非全是坏消息:在这一令人遗憾的更新之后,另一位粉丝询问了另外两部 DC 电视剧的进展:讲述一个患有冒名顶替综合症的英雄故事的《Booster Gold》,以及以 Wonder Woman 的故乡 Themyscira 为背景的政治剧《Paradise Lost》。“BG 正在开发中,”Gunn 回复道。“PL 处于深度开发阶段。”因此,即使目前有一部电影无法推进,其他项目也在反过来加速推进。但这就是在项目刚开始开发时就获悉消息所付出的代价——有时,事情并不会如愿以偿。这一切又回到了每个粉丝必须问自己的那个永恒问题:是宁愿知道一个项目却最终失去它,还是从未听说过它更好?本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。